摘要:
Orally or parenterally administrable pharmaceutical compositions in unit dosage form comprise from about 100 to about 500 mg of one of the compounds of formula (I). ##STR1## wherein R is selected from: 2-(N,N-diisopropyl)aminoethyl,2-aminoethyl,2-N-(pyrrolidin-2-one-1-yl)acetyl aminoethyl,2-phenylethyl,benzyl,2-N-(pyroglutamylglycyl)aminoethyl,2-N-(pyroglutamyl)aminoethyl;Y is either a C--N single bond or the bivalent residue of an aminoacid selected from: ##STR2## are potent enhancers of the learning processes and memory.
摘要:
1,2,3,4-tetrahydronaphthlamines of formula (1) ##STR1## wherein R is H or OCH.sub.3 ; ##STR2## is either at 1 or 2 position R.sub.1 is H;R.sub.2 is selected from:L-prolyl, optionally N-substituted with acetyl or carbobenzoxy,L-pyroglutamyl,(pyrrolidin-2-one-1-yl)acetyl,3-carboxy-2-hydroxypropyl:or R.sub.1 and R.sub.2 taken together with the nitrogen atom form the ring ##STR3## wherein n=1,2,3 and R.sub.3 -H, OH are nootropic substances potent enhancers of learning processes and memory.Orally or parenterally administrable pharmaceutical compositions in unit dosage form comprise between about 100 and about 500 mg of a compound of formula (1).
摘要:
1-alkyl-3-(acylamino)-.epsilon.-caprolactames of formula (1) ##STR1## wherein R is selected from the group consisting of:pyrrolidin-2-one-1-acetyl,p-methoxybenzoyl,N-benzyloxycarbonyl-(S)-prolyl,phenylbutanoyl,3-trifluoromethylbenzoyl,3,4,5-trimethoxybenzoyl,nicotinoyl, andacyl having from 1 to 5 carbon atoms, andR.sub.1 is selected from the group consisting of:hydrogen,methoxycarbonylmethyl,aminocarbonylmethyl,2-hydroxyethyl, andformylmethyl,(provided that, if R.sub.1 is hydrogen, R is not formyl or acetyl) are potent enhancers of learning and memory.Orally or parenterally administrable pharmaceutical compositions in unit dosage form comprise from about 100 to 500 mg of one of the compound of formula (1).
摘要:
Pharmaceutical compositions for enhancing the process of learning and memory are disclosed, that contain as active principle a 3-amino-.epsilon.-caprolactam of formula (1) ##STR1## Wherein R is selected from the group consisting of hydrogen, formyl and acetyl.Orally or parenterally administrable pharmaceutical compositions in unit dosage form comprise from about 100 to about 500 mg of a compound of formula (1).